In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Wilex raises €30mm in Series C round

Executive Summary

Cancer therapeutics company Wilex AG raised €30mm ($39mm) in its Series C venture round. Merlin Biosciences led, and was joined by new investors Karolinska Investment Fund, Quest for Growth, and Quintiles PharmaBio, as well as existing backers Apax Partners, TVM Techno Venture Management, Earlybird Venture Capital, and other institutional and private investors.
Deal Industry
  • Pharmaceuticals
  • Biotechnology
    • Large Molecule
      • Antibodies
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies